>
Organization
MorphoSys AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on MorphoSys AG

... DGAP-News: Please note MorphoSys's financial reporting dates 2019 as follows: Dear Madam/Sir, : Corporate Calendar 2019 ...
... PASI 90 at Week 48 in the Treatment of Plaque Psoriasis DGAP-News: MorphoSys AG / Key word(s): Study results MorphoSys's Licensee Janssen Announces Data from ...
... at Week 48 in the Treatment of Moderate to Severe Psoriasis DGAP-Ad-hoc: MorphoSys AG / Key word(s): Miscellaneous Ad hoc: MorphoSys Announces that According to ...
... Lenalidomide in r/r DLBCL at ASH 2018 DGAP-News: MorphoSys AG / Key word(s): Study results/Conference MorphoSys Presents Updated Data from L-MIND ...
... the Treatment of Patients with Palmoplantar Pustulosis DGAP-News: MorphoSys AG / Key word(s): Regulatory Approval MorphoSys Announces Approval of Tremfya(R) (Guselkumab) ...
... SuppurativaFirst patient dosed in phase II trial with IFX-1 in ANCA-associated vasculitis MorphoSys AGBoard of Directors appointment Jens Holstein, Chief Financial Officer of JENA, Germany, ...
... (NOVA) to Evaluate Guselkumab in Hidradenitis Suppurativa DGAP-News: MorphoSys AG / Key word(s): Study MorphoSys Announces Its Licensee Janssen Initiated a ...
... MorphoSys has partnered with I-Mab to support development of anti-C5aR antibody MOR210. The ...
... MorphoSys's Novel Immuno-Oncology Agent MOR210 DGAP-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys ...
... DGAP-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement 2:00pm CET (1:00pm GMT ...
Subscribe now for full coverage on MorphoSys AG
Start My Free Trial